June 17, 2026

New Drugs, New Delivery Systems: The New Landscape of Ophthalmic Therapeutics

Mitch Ibach, OD, FAAO, and Jake Lang, OD, FAAO, review what optometrists need to know about mechanism-based treatment in dry eye, glaucoma, presbyopia, and immune-mediated and inflammatory eye disease.

Optometric Management

June 17, 2026

Herpetic Eye Disease Is Not a Single Event

Joseph P. Shovlin, OD, FAAO, reviewed diagnosis, management, and emerging evidence related to chronic herpetic eye disease prevention at Optometry's Meeting 2026.

Optometric Management

May 21, 2026

New Target for Uveitis Therapy

Could targeting cGAS-STING represent a new treatment avenue for uveitis?

The Ophthalmologist

May 15, 2026

Smoking Doubles Risk of Vision Loss

New research indicates smoking doubles the risk of multiple sight-threatening conditions

The Ophthalmologist

May 07, 2026

Vamikibart Shows Early Safety in Uveitic Macular Edema

Phase 1 nonrandomized trial reported no drug-related serious adverse events, but efficacy remains unproven

Conexiant

May 04, 2026

The Art of Ophthalmology 2026

Showcasing artwork and images from across the spectrum of ophthalmology

The Ophthalmologist

May 01, 2026

Clinical Trial Update May/June 2026

Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.

Retinal Physician

May 01, 2026

Tattoo-Associated Uveitis: What Primary Eye Care Needs to Know in 2026

Drs. Cass and Wolfe review recent research on tattoo-associated uveitis and offer practcal takeaways in uveitis cases.

Optometric Management

May 01, 2026

New Tools for Imaging Retinal Inflammation

At ARVO 2026, Ethan A. Rossi, PhD, presented data on multimodal AOSLO imaging of immune cells in the living eye.

Ophthalmology Management

May 01, 2026

Imaging Leukocyte Dynamics in Retinal Disease

The movement of immune cells through the retinal vasculature has long been inferred from laboratory models. Now, advances in imaging are allowing clinicians to observe these processes directly. At the 2026 meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Denver, Richard B. Rosen, MD, ScD(hon), FACS, FASRS, FARVO, described early clinical work using adaptive optics scanning laser ophthalmoscopy (AOSLO) to visualize leukocyte trafficking in vivo.

Retinal Physician